1 / 9

ENT Clinical Trials Programme

ENT Clinical Trials Programme. Professor Anne Schilder - Director. ENT- The Hidden Giant. Upper respiratory tract infections 6 million GP consultations most common reason for antibiotics and surgery in children costs of antibiotics for URTI £24 million. Allergy

stone-holden
Download Presentation

ENT Clinical Trials Programme

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. ENT Clinical Trials Programme Professor Anne Schilder- Director

  2. ENT- The Hidden Giant • Upper respiratory tract infections • 6 million GP consultations • most common reason for antibiotics and surgery in children • costs of antibiotics for URTI £24 million • Allergy • 3 million GP consultations • 4.5 million GP prescriptions for nasal allergies • costs of prescriptions £0.9 billion • Hearing loss • 10 million people in UK • 70% of people over 70 years • 40% experience mental health problems • costs of unemployment because of unaided hearing loss £13.5 billion • Balance problems • 14 million GP consultations • benefits claimed for dizziness £ 24 million

  3. ENT Clinical Research Activity

  4. Programme Aim • Establish the world leading ENT Clinical Trials Programme at UCL • Develop the evidence base for ENT

  5. Pathway of Translation to Practice BENCH BEDSIDE PRACTICE T1 Case studies Phase 1 and 2 Clinical Trials • Basic Science Research • Preclinical studies • Animal Research • Human Clinical Research • Controlledobservational studies • Phase 3 clinical trials • ClinicalPractice • Delivery of recommendede care to the right patient at the right time • Identification of new clinicalquestionsandgaps in care T2 TRANSLATION TO HUMANS • T2 • Guidelinedevelopment • Meta-analyses • Systematic research • T3 • Dissemination research • Implementation research • Practice-Based Research • Phase 3 and 4 clinical trials • Observational studies • Survey research TRANSLATION TO PATIENTS TRANSLATION TO PRACTICE

  6. Current Research Strengths at UCL Ear Institute Stem cell facilities UCL Clinical Biomedical Research Centre UCL Partners BENCH BEDSIDE PRACTICE T1 Case studies Phase 1 and 2 Clinical Trials • Basic Science Research • Preclinical studies • Animal Research • Human Clinical Research • Controlledobservational studies • Phase 3 clinical trials • ClinicalPractice • Delivery of recommendede care to the right patient at the right time • Identification of new clinicalquestionsandgaps in care T2 TRANSLATION TO HUMANS UCL Faculty of Population Health Sciences • T2 • Guidelinedevelopment • Meta-analyses • Systematic research • T3 • Dissemination research • Implementation research • Practice-Based Research • Phase 3 and 4 clinical trials • Observational studies • Survey research TRANSLATION TO PATIENTS TRANSLATION TO PRACTICE

  7. The Missing Link ENT Clinical Trials Programme UCL Clinical Trials Unit UCL Joint Research Office UCL Clinical Research Facility UCL Partners Ear Institute Stem cell facilities UCL Clinical Biomedical Research Centre BENCH BEDSIDE PRACTICE T1 Case studies Phase 1 and 2 Clinical Trials • Basic Science Research • Preclinical studies • Animal Research • Human Clinical Research • Controlledobservational studies • Phase 3 clinical trials • ClinicalPractice • Delivery of recommendede care to the right patient at the right time • Identification of new clinicalquestionsandgaps in care T2 TRANSLATION TO HUMANS UCL Faculty of Population Health Sciences • T2 • Guidelinedevelopment • Meta-analyses • Systematic research • T3 • Dissemination research • Implementation research • Practice-Based Research • Phase 3 and 4 clinical trials • Observational studies • Survey research TRANSLATION TO PATIENTS TRANSLATION TO PRACTICE

  8. Key Steps • Work with the Cochrane ENT Disorders group to summarise what is known about treatments and prevention of ENT conditions • Engage clinicians and form national and international collaborations spanning the translational pathway • Obtain funding, develop and open new studies and trials • Work with the UK Clinical Research Network ENT Speciality Group • Disseminate the findings and develop evidence based guidelines • Develop the next generation of research leaders in ENT

  9. Achievements so far • Joint joint Co-ordinating Editor of the Cochrane ENT Disorders Group • Chair of the National and Local Central and East London ENT Specialty Group of the NIHR Clinical Research Network • NIHR Research Professorship • ‘ New research professors will help treatments make the • leap from the bench to the bedside’ February 15, 2012

More Related